295 related articles for article (PubMed ID: 17156977)
21. Acute treatment with morphine augments the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain.
Yoshikawa M; Andoh H; Ito K; Suzuki T; Kawaguchi M; Kobayashi H; Oka T; Hashimoto A
Eur J Pharmacol; 2005 Nov; 525(1-3):94-7. PubMed ID: 16256980
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients.
Fuchs SA; De Barse MM; Scheepers FE; Cahn W; Dorland L; de Sain-van der Velden MG; Klomp LW; Berger R; Kahn RS; de Koning TJ
Eur Neuropsychopharmacol; 2008 May; 18(5):333-8. PubMed ID: 18261886
[TBL] [Abstract][Full Text] [Related]
23. D-Amino acid metabolism in mammals: biosynthesis, degradation and analytical aspects of the metabolic study.
Ohide H; Miyoshi Y; Maruyama R; Hamase K; Konno R
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(29):3162-8. PubMed ID: 21757409
[TBL] [Abstract][Full Text] [Related]
24. Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development.
Wang LZ; Zhu XZ
Acta Pharmacol Sin; 2003 Oct; 24(10):965-74. PubMed ID: 14531937
[TBL] [Abstract][Full Text] [Related]
25. Alteration of intrinsic amounts of D-serine in the mice lacking serine racemase and D-amino acid oxidase.
Miyoshi Y; Konno R; Sasabe J; Ueno K; Tojo Y; Mita M; Aiso S; Hamase K
Amino Acids; 2012 Nov; 43(5):1919-31. PubMed ID: 22990841
[TBL] [Abstract][Full Text] [Related]
26. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
Nadri C; Dean B; Scarr E; Agam G
Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
[TBL] [Abstract][Full Text] [Related]
27. Effects of lead exposure on D-serine metabolism in the hippocampus of mice at the early developmental stages.
Yu H; Li T; Cui Y; Liao Y; Wang G; Gao L; Zhao F; Jin Y
Toxicology; 2014 Nov; 325():189-99. PubMed ID: 25242007
[TBL] [Abstract][Full Text] [Related]
28. Subchronic administration of ketamine decreases the mRNA expression of serine racemase in rat brain.
Watanabe M; Yoshikawa M; Takeyama K; Hashimoto A; Kobayashi H; Suzuki T
Tokai J Exp Clin Med; 2010 Dec; 35(4):137-43. PubMed ID: 21319044
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with morphine increases the D-serine content in the rat brain by regulating the mRNA and protein expressions of serine racemase and D-amino acid oxidase.
Yoshikawa M; Shinomiya T; Takayasu N; Tsukamoto H; Kawaguchi M; Kobayashi H; Oka T; Hashimoto A
J Pharmacol Sci; 2008 Jul; 107(3):270-6. PubMed ID: 18603832
[TBL] [Abstract][Full Text] [Related]
30. D-amino acids in the brain: structure and function of pyridoxal phosphate-dependent amino acid racemases.
Yoshimura T; Goto M
FEBS J; 2008 Jul; 275(14):3527-37. PubMed ID: 18564179
[TBL] [Abstract][Full Text] [Related]
31. In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.
Puhl MD; Mintzopoulos D; Jensen JE; Gillis TE; Konopaske GT; Kaufman MJ; Coyle JT
Neurobiol Dis; 2015 Jan; 73():269-74. PubMed ID: 25461193
[TBL] [Abstract][Full Text] [Related]
32. Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia.
Ohnuma T; Shibata N; Maeshima H; Baba H; Hatano T; Hanzawa R; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):511-8. PubMed ID: 19223009
[TBL] [Abstract][Full Text] [Related]
33. [Endogenous D-serine in mammalian brains].
Nishikawa T; Yamamoto N; Tsuchida H; Umino A; Kawaguchi N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Feb; 20(1):33-9. PubMed ID: 10890022
[TBL] [Abstract][Full Text] [Related]
34. Characterization and localization of a human serine racemase.
Xia M; Liu Y; Figueroa DJ; Chiu CS; Wei N; Lawlor AM; Lu P; Sur C; Koblan KS; Connolly TM
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):96-104. PubMed ID: 15193426
[TBL] [Abstract][Full Text] [Related]
35. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
Port JD; Unal SS; Mrazek DA; Marcus SM
Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
[TBL] [Abstract][Full Text] [Related]
36. Contributions of the D-serine pathway to schizophrenia.
Labrie V; Wong AH; Roder JC
Neuropharmacology; 2012 Mar; 62(3):1484-503. PubMed ID: 21295046
[TBL] [Abstract][Full Text] [Related]
37. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.
D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P
Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064
[TBL] [Abstract][Full Text] [Related]
38. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A
Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.
Luykx JJ; Bakker SC; Visser WF; Verhoeven-Duif N; Buizer-Voskamp JE; den Heijer JM; Boks MP; Sul JH; Eskin E; Ori AP; Cantor RM; Vorstman J; Strengman E; DeYoung J; Kappen TH; Pariama E; van Dongen EP; Borgdorff P; Bruins P; de Koning TJ; Kahn RS; Ophoff RA
Mol Psychiatry; 2015 Dec; 20(12):1557-64. PubMed ID: 25666758
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.
Karry R; Klein E; Ben Shachar D
Biol Psychiatry; 2004 Apr; 55(7):676-84. PubMed ID: 15038995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
